Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

被引：5
|
作者：
Micale, Sara J. D. [1 ]
Kane, Michael P. [1 ]
Hogan, Eileen [2 ]
机构：
[1] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, 106 New Scotland Ave, Albany, NY 12208 USA
[2] Endocrine Grp LLP, Albany, NY 12206 USA
来源：
CASE REPORTS IN PEDIATRICS | 2013年 / 2013卷
关键词：
D O I：
10.1155/2013/703925
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increases satiety, and delays gastric emptying. Liraglutide, unlike metformin and insulin, is not approved for use in the pediatric population. We report the successful off-label use of liraglutide in an obese, 16 year old Caucasian female with type 2 diabetes mellitus.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Off-label use of Liraglutide in paediatric Type 2 diabetes mellitus
    Reade, E.
    Dunne, E.
    McGrath, N.
    Murphy, N.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S191 - S191
  • [2] Liraglutide/prednisoloneDiabetes mellitus and off-label use : case report
    [J]. Reactions Weekly, 2022, 1935 (1) : 245 - 245
  • [3] Off label use of CGM in a pediatric patient with type 1 Diabetes Mellitus under the age of 2
    Burdea, Liliana
    Robinson, Sylvia
    Mantis, Stelios
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 523 - 523
  • [4] Patient Experiences with Use of Liraglutide for Pediatric Type 2 Diabetes
    Sanchez-Kleinberg, Yesenia
    Hitt, Talia
    Vazquez-Diaz, Sandra
    Katz, Lorraine
    Vajravelu, Mary Ellen
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 43 - 44
  • [5] Prednisolone/unspecified antibacterialsVesical mucormycosis, type 2 diabetes mellitus and off-label use: case report
    [J]. Reactions Weekly, 2022, 1931 (1) : 500 - 500
  • [6] Liraglutide A Review of its Use in the Management of Type 2 Diabetes Mellitus
    Perry, Caroline M.
    [J]. DRUGS, 2011, 71 (17) : 2347 - 2373
  • [7] Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection
    Sheffield, Catherine A.
    Kane, Michael P.
    Busch, Robert S.
    [J]. PHARMACOTHERAPY, 2007, 27 (10): : 1449 - 1455
  • [8] Type 2 diabetes in youth: Rationale for use of off-label antidiabetic agents
    Kelsey, Megan M.
    Zeitler, Philip S.
    Nadeau, Kristen J.
    Shah, Amy S.
    [J]. PEDIATRIC DIABETES, 2022, 23 (06) : 615 - 619
  • [9] Guideline for the management of pediatric off-label use of drugs in China (2021)
    Min Meng
    Enmei Liu
    Bo Zhang
    Quan Lu
    Xiaobo Zhang
    Bin Ge
    Ye Wu
    Li Wang
    Mo Wang
    Zhengxiu Luo
    Ziyu Hua
    Xiaoling Wang
    Wei Zhao
    Yi Zheng
    Xinan Wu
    Ruiling Zhao
    Wenbo Meng
    Li Xiang
    Gang Wang
    Yuntao Jia
    Yongchuan Chen
    Xiaoyan Dong
    Lina Hao
    Chengjun Liu
    Meng Lv
    Xufei Luo
    Yunlan Liu
    Quan Shen
    Wenjuan Lei
    Ping Wang
    Yajia Sun
    Juanjuan Zhang
    Ling Wang
    Ruobing Lei
    Tianchun Hou
    Bo Yang
    Qiu Li
    Yaolong Chen
    [J]. BMC Pediatrics, 22
  • [10] Guideline for the management of pediatric off-label use of drugs in China (2021)
    Meng, Min
    Liu, Enmei
    Zhang, Bo
    Lu, Quan
    Zhang, Xiaobo
    Ge, Bin
    Wu, Ye
    Wang, Li
    Wang, Mo
    Luo, Zhengxiu
    Hua, Ziyu
    Wang, Xiaoling
    Zhao, Wei
    Zheng, Yi
    Wu, Xinan
    Zhao, Ruiling
    Meng, Wenbo
    Xiang, Li
    Wang, Gang
    Jia, Yuntao
    Chen, Yongchuan
    Dong, Xiaoyan
    Hao, Lina
    Liu, Chengjun
    Lv, Meng
    Luo, Xufei
    Liu, Yunlan
    Shen, Quan
    Lei, Wenjuan
    Wang, Ping
    Sun, Yajia
    Zhang, Juanjuan
    Wang, Ling
    Lei, Ruobing
    Hou, Tianchun
    Yang, Bo
    Li, Qiu
    Chen, Yaolong
    [J]. BMC PEDIATRICS, 2022, 22 (01)
12345